BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12585347)

  • 1. Polyglandular autoimmune syndrome type 1 without chronic mucocutaneous candidiasis in a 16 year-old male.
    Bhansali A; Kotwal N; Suresh V; Murlidharan R; Chattopadhyay A; Mathur K
    J Pediatr Endocrinol Metab; 2003 Jan; 16(1):103-5. PubMed ID: 12585347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucocutaneous candidiasis as first manifestation of autoimmune polyglandular syndrome type I.
    López-Jornet P; García-Ballesta C; Pérez-Lajarín L
    J Dent Child (Chic); 2005; 72(1):21-4. PubMed ID: 16119071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyglandular autoimmune syndrome-type I.
    Joshi RR; Rao S; Prabhu SS
    Indian Pediatr; 2006 Dec; 43(12):1085-7. PubMed ID: 17202607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone deficiency in autoimmune polyglandular disease type 1.
    Al-Herbish AS; Bailey JD; Kooh SW
    Saudi Med J; 2000 Aug; 21(8):765-8. PubMed ID: 11423892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune polyendocrinopathy and chronic mucocutaneous candidiasis].
    Proto G; Leoni S; Torossi I; Mazzolini A; Grimaldi F; Bertolissi F
    Minerva Med; 1992; 83(7-8):475-8. PubMed ID: 1522973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I.
    Carboni I; Soda R; Bianchi L; Chimenti S
    Acta Derm Venereol; 2002; 82(1):68-9. PubMed ID: 12013209
    [No Abstract]   [Full Text] [Related]  

  • 7. A Case of Critical Lower-Limb Ischemia in a 29-Year-Old Man with Autoimmune Polyglandular Syndrome Type 1 (APS-1).
    Ennab RM; Saadeh NA
    Am J Case Rep; 2020 Oct; 21():e924705. PubMed ID: 33068390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune polyglandular syndrome type I. A case report.
    Cinaz P; Bideci A; Haznedaroğlu A; Ezgü FS; Ağaoğlu O; Kürşaklioğlu S
    Turk J Pediatr; 1997; 39(2):271-5. PubMed ID: 9223927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune polyglandular syndrome (APS) type 1 and candida onychomycosis.
    Manz B; Scholz GH; Willgerodt H; Haustein UF; Nenoff P
    Eur J Dermatol; 2002; 12(3):283-6. PubMed ID: 11978574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyglandular autoimmune (PGA) syndromes: report of three cases and review of the literature.
    Bunnag P; Rajatanavin R
    J Med Assoc Thai; 1994 Jun; 77(6):327-33. PubMed ID: 7869020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral manifestations of autoimmune polyglandular syndrome type 1.
    Tenório JR; Tuma MM; Andrade NS; Santana T; Gallottini M
    Spec Care Dentist; 2022 Sep; 42(5):531-535. PubMed ID: 35182449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical presentation of autoimmune polyglandular syndrome type 1 in the fifth decade.
    Sanjeevi A; Asirvatham AR; Balachandran K; Mahadevan S
    BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33906891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varying presentation of type 1 polyglandular failure in India.
    Laway BA; Ganie MA; War FA; Mir SA; Roshan R; Zargar AH
    J Pediatr Endocrinol Metab; 2010 Mar; 23(3):271-6. PubMed ID: 20480726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2-induced adrenal crisis in a patient with autoimmune polyglandular syndrome type 1: case report.
    Nyagolova P; Mitkov M; Sapundzhiev L
    Folia Med (Plovdiv); 2023 Apr; 65(2):305-310. PubMed ID: 37144317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of common variable immunodeficiency and autoimmune polyglandular syndrome type 2.
    Topaloglu AK; Yuksel B; Yilmaz M; Mungan NO; Guneser S; Ozer G
    J Pediatr Endocrinol Metab; 2001 May; 14(5):565-6. PubMed ID: 11393580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of polyglandular autoimmune syndrome (PGA) type 1 complicated with slowly progressive IDDM].
    Isotani H; Suzuki K; Fukumoto Y; Omote Y; Furukawa K
    Nihon Naibunpi Gakkai Zasshi; 1995 Jan; 71(1):65-72. PubMed ID: 7895866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic consequences of autoimmune polyglandular syndrome type 1.
    Berger JR; Weaver A; Greenlee J
    Neurology; 2008 Jun; 70(23):2248-51. PubMed ID: 18519874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune Polyglandular Syndrome Type 2 with Alopecia Universalis and Hypoparathyroidism.
    Dave P; Bhosle D; Dharme M; Deshmukh D; Patel J
    J Assoc Physicians India; 2015 Apr; 63(4):74-6. PubMed ID: 26591178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune adrenal insufficiency in children: a hint for polyglandular syndrome type 2?
    Arrigoni M; Cavarzere P; Nicolussi Principe L; Gaudino R; Antoniazzi F
    Ital J Pediatr; 2023 Jul; 49(1):94. PubMed ID: 37516895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enamel hypoplasia secondary to candidiasis endocrinopathy syndrome: case report.
    Porter SR; Eveson JW; Scully C
    Pediatr Dent; 1995; 17(3):216-9. PubMed ID: 7617499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.